The FDA approved human trials after initially rejecting them in 2022, citing safety concerns.
The FDA had initially rejected the company’s request to run human trials back in 2022, citing safety concerns.
The FDA approved human trials after initially rejecting them in 2022, citing safety concerns.
The FDA had initially rejected the company’s request to run human trials back in 2022, citing safety concerns.
Comments are closed.